Header

UZH-Logo

Maintenance Infos

Prediction of hepatocellular carcinoma response to Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results


Gordic, Sonja; Wagner, Mathilde; Zanato, Riccardo; Hectors, Stefanie; Besa, Cecilia; Kihira, Shingo; Kim, Edward; Taouli, Bachir (2019). Prediction of hepatocellular carcinoma response to Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results. Cancer Imaging, 19(1):29.

Abstract

PURPOSE
To assess the predictive value of volumetric apparent diffusion coefficient (vADC) histogram quantification obtained before and 6 weeks (6w) post-treatment for assessment of hepatocellular carcinoma (HCC) response to Yttrium radioembolization (RE).
METHODS
In this retrospective study, 22 patients (M/F 15/7, mean age 65y) who underwent lobar RE were included between October 2013 and November 2014. All patients underwent routine liver MRI pre-treatment and 6w after RE. Two readers assessed index tumor response at 6 months after RE in consensus, using mRECIST criteria. vADC histogram parameters of index tumors at baseline and 6w, and changes in vADC (ΔvADC) histogram parameters were calculated. The predictive value of ADC metrics was assessed by logistic regression with stepwise parameter selection and ROC analyses.
RESULTS
Twenty two HCC lesions (mean size 3.9 ± 2.9 cm, range 1.2-12.3 cm) were assessed. Response at 6 months was as follows: complete response (CR, n = 6), partial response (PR, n = 3), stable disease (SD, n = 12) and progression (PD, n = 1). vADC median/mode at 6w (1.81-1.82 vs. 1.29-1.35 × 10 mm/s) and ΔvADC median/max (27-44% vs. 0-10%) were significantly higher in CR/PR vs. SD/PD (p = 0.011-0.036), while there was no significant difference at baseline. Logistic regression identified vADC median at 6w as an independent predictor of response (CR/PR) with odds ratio (OR) of 3.304 (95% CI: 1.099-9.928, p = 0.033) and AUC of 0.77. ΔvADC mean was identified as an independent predictor of CR with OR of 4.153 (95%CI: 1.229-14.031, p = 0.022) and AUC of 0.91.
CONCLUSION
Diffusion histogram parameters obtained at 6w and early changes in ADC from baseline are predictive of subsequent response of HCCs treated with RE, while pre-treatment vADC histogram parameters are not. These results need confirmation in a larger study.
TRIAL REGISTRATION
This retrospective study was IRB-approved and the requirement for informed consent was waived.

Abstract

PURPOSE
To assess the predictive value of volumetric apparent diffusion coefficient (vADC) histogram quantification obtained before and 6 weeks (6w) post-treatment for assessment of hepatocellular carcinoma (HCC) response to Yttrium radioembolization (RE).
METHODS
In this retrospective study, 22 patients (M/F 15/7, mean age 65y) who underwent lobar RE were included between October 2013 and November 2014. All patients underwent routine liver MRI pre-treatment and 6w after RE. Two readers assessed index tumor response at 6 months after RE in consensus, using mRECIST criteria. vADC histogram parameters of index tumors at baseline and 6w, and changes in vADC (ΔvADC) histogram parameters were calculated. The predictive value of ADC metrics was assessed by logistic regression with stepwise parameter selection and ROC analyses.
RESULTS
Twenty two HCC lesions (mean size 3.9 ± 2.9 cm, range 1.2-12.3 cm) were assessed. Response at 6 months was as follows: complete response (CR, n = 6), partial response (PR, n = 3), stable disease (SD, n = 12) and progression (PD, n = 1). vADC median/mode at 6w (1.81-1.82 vs. 1.29-1.35 × 10 mm/s) and ΔvADC median/max (27-44% vs. 0-10%) were significantly higher in CR/PR vs. SD/PD (p = 0.011-0.036), while there was no significant difference at baseline. Logistic regression identified vADC median at 6w as an independent predictor of response (CR/PR) with odds ratio (OR) of 3.304 (95% CI: 1.099-9.928, p = 0.033) and AUC of 0.77. ΔvADC mean was identified as an independent predictor of CR with OR of 4.153 (95%CI: 1.229-14.031, p = 0.022) and AUC of 0.91.
CONCLUSION
Diffusion histogram parameters obtained at 6w and early changes in ADC from baseline are predictive of subsequent response of HCCs treated with RE, while pre-treatment vADC histogram parameters are not. These results need confirmation in a larger study.
TRIAL REGISTRATION
This retrospective study was IRB-approved and the requirement for informed consent was waived.

Statistics

Citations

Dimensions.ai Metrics
5 citations in Web of Science®
5 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

13 downloads since deposited on 31 Jul 2019
4 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Diagnostic and Interventional Radiology
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Radiological and Ultrasound Technology
Health Sciences > Oncology
Health Sciences > Radiology, Nuclear Medicine and Imaging
Language:English
Date:29 May 2019
Deposited On:31 Jul 2019 10:44
Last Modified:01 Jul 2020 13:37
Publisher:BioMed Central
ISSN:1470-7330
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1186/s40644-019-0216-6
PubMed ID:31142363

Download

Gold Open Access

Download PDF  'Prediction of hepatocellular carcinoma response to Yttrium radioembolization using volumetric ADC histogram quantification: preliminary results'.
Preview
Content: Published Version
Filetype: PDF
Size: 2MB
View at publisher
Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)